Zaetta Christopher R reported acquisition or exercise transactions in this Form 4 filing.
UNITEDHEALTH GROUP INC EVP & Chief Legal Officer Christopher R. Zaetta received 60.691 shares of common stock as a grant of dividend equivalents tied to existing restricted stock units. The award carried no purchase price and increased his directly held common stock to 15,859.84 shares.
The dividend equivalents will vest or be forfeited under the same terms as the underlying restricted stock units. A separate June 8, 2026 transfer of shares and options was exempt from Section 16 reporting under applicable SEC rules.
DeVeydt Wayne S reported acquisition or exercise transactions in this Form 4 filing.
UNITEDHEALTH GROUP INC Chief Financial Officer Wayne S. DeVeydt reported receiving a grant of 111.76 shares of common stock on June 23, 2026. The award reflects dividend equivalents paid on his outstanding restricted stock units and carries a grant price of $0.00 per share.
The dividend equivalents are subject to the same vesting terms as the underlying restricted stock units and will be forfeited if those units do not vest. Following this compensation-related award, DeVeydt directly holds 19,778.69 shares of UnitedHealth Group common stock.
HEMSLEY STEPHEN J reported acquisition or exercise transactions in this Form 4 filing.
UnitedHealth Group director and CEO Stephen J. Hemsley reported routine equity updates. He received 46 shares of Common Stock as dividend equivalents on vested deferred stock units at $0.00 per share, raising his direct holdings to 48,098.942 shares.
Indirect holdings now include 1,006,831 shares by trusts and 356.8592 shares via a 401(k). Footnotes state that earlier large-share movements between his direct holdings and trusts were exempt transfers under Section 16 rules, reflecting internal reallocations rather than market trades.
UnitedHealth Group’s Chief Accounting Officer Dennis Andrew Stankiewicz reported a small equity-related acquisition through a Form 4. He received 50.590 shares of common stock as dividend equivalents on outstanding restricted stock units, at a stated price of $0.00 per share.
These dividend equivalents are subject to the same vesting and forfeiture terms as the underlying restricted stock units. Following this award, his directly held common stock position reported in the filing increased to 10,256.529 shares, indicating a routine, compensation-linked update rather than an open-market transaction.
Baker Charles D. reported acquisition or exercise transactions in this Form 4 filing.
UNITEDHEALTH GROUP INC director Charles D. Baker received 13 shares of common stock as dividend equivalents on vested deferred stock units. These dividend-equivalent shares are immediately vested and carry the same terms as the underlying deferred stock units. Following this compensation-related award, Baker directly holds 2,176 shares of UnitedHealth Group common stock.
UNITEDHEALTH GROUP INC director Frederick William McNabb III received a grant tied to existing deferred stock units. On this Form 4, he acquired 50 shares of Common Stock at a price of $0.00 per share as dividend equivalents on vested deferred stock units. After this award, he directly holds 15,212 shares of UnitedHealth Group common stock. The dividend equivalents are immediately vested and are subject to the same terms as the underlying deferred stock units.
UNITEDHEALTH GROUP INC director Timothy Patrick Flynn reported routine equity compensation activity. He acquired 61 shares of Common Stock at $0.0000 per share as a grant or award on June 23, 2026. A footnote explains these represent dividend equivalents paid on vested deferred stock units, which are immediately vested and follow the same terms as the underlying units.
After this award, Flynn directly holds 10,650 shares of Common Stock and indirectly holds 6,033 shares through a trust. The filing reflects compensation-related share accruals rather than any open-market buying or selling.
UnitedHealth Group executive Patrick Hugh Conway, Chief Executive Officer of Optum, reported a tax-related share disposition. On June 5, 2026, 686.861 shares of common stock were withheld at $399.47 per share to cover tax obligations, leaving him with 16,914.309 directly held shares.
UnitedHealth Group Incorporated reported the results of its 2026 Annual Meeting of Shareholders. A total of 768,066,717 shares of common stock were represented. Shareholders elected nine directors for one-year terms, with support levels generally above 89% of votes cast for each nominee.
Shareholders approved, on a non-binding basis, the Company’s executive compensation, with 559,434,838 votes for and 82.74% of votes cast in favor. They also ratified the appointment of Deloitte & Touche LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026, with 95.00% of votes cast in favor. A shareholder proposal to require any board chair to be independent received 20.24% support and was not approved.
UnitedHealth Group executive Christopher R. Zaetta reported a small, routine tax-related share disposition. On this Form 4, he used 134.02 shares of UnitedHealth Group common stock, valued at $377.00 per share, to satisfy tax obligations. After this tax-withholding disposition, he continues to hold 16,582.149 shares directly, indicating the transaction affects only a minor portion of his overall position and does not represent an open-market sale.